[1] |
Silverberg JI. Practice gaps in pruritus[J]. Dermatol Clin, 2016,34(3):257⁃261. doi: 10.1016/j.det.2016.02.008.<br />
|
[2] |
Weisshaar E, Szepietowski JC, Darsow U, et al. European guideline on chronic pruritus[J]. Acta Derm Venereol, 2012,92(5):563⁃581. doi: 10.2340/00015555⁃1400.<br />
|
[3] |
Rajagopalan M, Saraswat A, Godse K, et al. Diagnosis and management of chronic pruritus: an expert consensus review[J]. Indian J Dermatol, 2017,62(1):7⁃17. doi: 10.4103/0019⁃5154. 198036.<br />
|
[4] |
Leader B, Carr CW, Chen SC. Pruritus epidemiology and quality of life[J]. Handb Exp Pharmacol, 2015,226:15⁃38. doi: 10.1007/978⁃3⁃662⁃44605⁃8_2.<br />
|
[5] |
Bolognila JL, Jorizzo JL, Rapini RP. 皮肤病学[M]. 朱学骏, 王宝玺, 孙建方, 等, 译. 2版. 北京: 北京大学医学出版社, 2011:123⁃139.<br />
|
[6] |
Reich A, Ständer S, Szepietowski JC. Drug⁃induced pruritus: a review[J]. Acta Derm Venereol, 2009,89(3):236⁃244. doi: 10. 2340/00015555⁃0650.<br />
|
[7] |
Bautista DM, Wilson SR, Hoon MA. Why we scratch an itch: the molecules, cells and circuits of itch[J]. Nat Neurosci, 2014,17(2):175⁃182. doi: 10.1038/nn.3619.<br />
|
[8] |
Berger TG, Shive M, Harper GM. Pruritus in the older patient: a clinical review[J]. JAMA, 2013,310(22):2443⁃2450. doi: 10. 1001/jama.2013.282023.<br />
|
[9] |
Pereira MP, Ständer S. Assessment of severity and burden of pruritus[J]. Allergol Int, 2017,66(1):3⁃7. doi: 10.1016/j.alit. 2016.08.009.<br />
|
[10] |
Yosipovitch G, Bernhard JD. Clinical practice. Chronic pruritus[J]. N Engl J Med, 2013,368(17):1625⁃1634. doi: 10.1056/NEJMcp1208814.<br />
|
[11] |
Ständer S, Zeidler C, Magnolo N, et al. Clinical management of pruritus[J]. J Dtsch Dermatol Ges, 2015,13(2):101⁃115; quiz 116. doi: 10.1111/ddg.12522.<br />
|
[12] |
中国中西医结合学会皮肤性病专业委员会环境与职业性皮肤病学组. 规范外用糖皮质激素类药物专家共识[J]. 中华皮肤科杂志, 2015,48(2):73⁃75. doi: 10.3760/cma.j.issn.0412⁃4030. 2015.02. 001.<br />
|
[13] |
中国中西医结合学会皮肤性病专业委员会环境与职业性皮肤病学组. 抗组胺药在皮肤科应用专家共识[J]. 中华皮肤科杂志, 2017,50(6):393⁃396. doi: 10.3760/cma.j.issn.0412⁃4030.2017. 06.001.<br />
|
[14] |
Matsuda KM, Sharma D, Schonfeld AR, et al. Gabapentin and pregabalin for the treatment of chronic pruritus[J]. J Am Acad Dermatol, 2016,75(3):619⁃625.e6. doi: 10.1016/j.jaad.2016.02. 1237.<br />
|
[15] |
Sharma D, Kwatra SG. Thalidomide for the treatment of chronic refractory pruritus[J]. J Am Acad Dermatol, 2016,74(2):363⁃369. doi: 10.1016/j.jaad.2015.09.039.<br />
|
[16] |
Cotes ME, Swerlick RA. Practical guidelines for the use of steroid⁃sparing agents in the treatment of chronic pruritus[J]. Dermatol Ther, 2013,26(2):120⁃134. doi: 10.1111/dth.12026.<br />
|